Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

University of Pennsylvania1,865 enrolled

Overview

The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

SINGLE

Enrollment

1,865

Conditions

Warfarin and NSAID

Interventions

Electronic AlertBEHAVIORAL

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania Exclusion Criteria: * None

Locations (1)

Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center

Philadelphia, Pennsylvania, United States

Outcomes

Primary Outcomes

Decreased rate of prescription of the combination of warfarin and NSAID

Time frame: 17 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.